Pfizer looks previous COVID with $43 bln offer for most cancers drug maker Seagen – Reuters

Pfizer appears to be past COVID with $43 bln deal for most cancers drug maker Seagen  ReutersPfizer Agrees to Obtain Seagen for $43 Billion  The Wall Street JournalPfizer appears further than Covid revenue with $43 billion deal for most cancers drugmaker Seagen  CNBCPfizer purchases Seagen for $43B, boosts access to most cancers drugs  ABC NewsBreakingviews – Pfizer’s $43 bln offer is a pricey pipeline fix  ReutersView Total Coverage on Google News

News Rant